Title : A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Pub. Date : 2001 Dec 6

PMID : 11759645






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In a post hoc analysis of the combined end point and mortality in subgroups defined according to base-line treatment with angiotensin-converting-enzyme (ACE) inhibitors or beta-blockers, valsartan had a favorable effect in patients receiving neither or one of these types of drugs but an adverse effect in patients receiving both types of drugs. Valsartan angiotensin I converting enzyme Homo sapiens
2 In a post hoc analysis of the combined end point and mortality in subgroups defined according to base-line treatment with angiotensin-converting-enzyme (ACE) inhibitors or beta-blockers, valsartan had a favorable effect in patients receiving neither or one of these types of drugs but an adverse effect in patients receiving both types of drugs. Valsartan angiotensin I converting enzyme Homo sapiens